Elisity could let IonQ earn security revenue before quantum computing reaches mass adoption. Its network controls complement quantum-safe encryption as customers prepare for harvest-now-decrypt-later attacks; AI agents could add demand. IonQ is now one of the most strategically important quantum security plays, but the roughly $1.3B deal adds integration risk amid strong competitors. Investors must watch whether security revenue grows organically or through more acquisitions. x.com 

IonQ's growing backlog and faster chip production strengthen its bullish case by securing future revenue and shortening production time. Q2 revenue jumped 287% YoY to $80M, beating expectations for a fifth straight quarter; backlog quadrupled to $485M and 2026 revenue guidance rose to $450M-$460M. SkyWater cuts chip production from nine to two months; 256-qubit bookings opened for early 2027 delivery, and the $1.3B Elisity acquisition targets quantum cybersecurity. x.com 

IonQ's acquisition of Elisity may make strategic sense but looks like a terrible deal at up to $1.3 billion, paid entirely in IonQ shares. The microsegmentation startup would cost roughly 9% of the company. x.com 

IonQ has assembled quite a few great assets by buying its way to legitimacy with an inflated stock price, including SkyWater's unique, mission-critical fab and Oxford Ionics. The CEO is a joke, but it never pays to bet against someone who can buy their way to success. x.com 

IonQ's acquisitions could compound by easing quantum scaling bottlenecks. IonQ says its chip cycle fell from nine to two months with SkyWater; Oxford Ionics, Nexus Photonics and Lightsynq add control, optics and interconnects. Networking, sensing and space may gain value before fault-tolerant computing. Its ecosystem may already be the world's most complex: ten investors might form ten theses with at most 75% overlap, perhaps overstated. Integration is hard; not every deal may deliver. x.com  … Show more

IonQ is hurting shareholders with a $2B raise to fund an acquisition that makes its business worse. Raising the money was a choice, not a necessity. The offering includes 20.5M common shares at $40 each and pre-funded warrants to purchase 29.5M shares at $40 per warrant, plus seven-year warrants for another 100M shares at $69.46. x.com  x.com 

IonQ is forming a massive cup pattern on heavy institutional accumulation, with institutions more than doubling their holdings over the past year. The quantum theme is also heating up, as Honeywell's Quantinuum IPO is reportedly 20x oversubscribed and begins trading today. x.com 

IonQ still looks like the quantum computing leader even though it was not directly named among the nine companies sharing the Trump administration's $2 billion in quantum grants. IBM is getting $1 billion and GlobalFoundries $375 million, with D-Wave, Rigetti, Infleqtion, Atom Computing, PsiQuantum and Quantinuum also listed. A move above 65.5 would mark continuation. x.com 

IonQ's $2 billion offering adds dilution risk without a quantum breakthrough. Chapman and Ballance's predicted 'ChatGPT moment' windows have elapsed; a circulated transcript has Monroe saying commercialization is 'probably not in 5 years.' The offering includes 50 million shares or equivalents and seven-year warrants for another 100 million. An up-to-$1.3 billion all-stock cybersecurity acquisition accompanies de Masi's claim that Q-Day is coming faster than predicted. x.com 

DARPA's Stage C endorsement bolsters IonQ's commercialization credibility and could finance validation of its fault-tolerant roadmap. Up to $300 million remains subject to future appropriations. IonQ also demonstrated more than 1,000 entanglements per second between trapped-ion qubits and solid-state memory, advancing its distributed quantum-network case; SkyWater's foundry supports its full-stack strategy. x.com  x.com